Cargando…
Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy
PURPOSE/BACKGROUND: Dopamine receptor blocking agents (DRBAs), also known as antipsychotics, are medications widely used to treat a growing number of mental health diagnoses. However, their utility is limited by the potential to cause serious adverse movement reactions. Akathisia, dystonia, parkinso...
Autores principales: | Musco, Shaina, Ruekert, Laura, Myers, Jaclyn, Anderson, Dennis, Welling, Michael, Cunningham, Elizabeth Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594730/ https://www.ncbi.nlm.nih.gov/pubmed/31205194 http://dx.doi.org/10.1097/JCP.0000000000001061 |
Ejemplares similares
-
Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment
por: Musco, Shaina, et al.
Publicado: (2020) -
Slovenian Version of the Drug-Induced Extrapyramidal Symptoms Scale: Evaluation of Interrater and Test-Retest Reliability
por: Senica, Nina, et al.
Publicado: (2023) -
Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System
por: Dorszewska, Jolanta
Publicado: (2014) -
POLR3A variants with striatal involvement and extrapyramidal movement disorder
por: Harting, Inga, et al.
Publicado: (2020) -
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D(2) receptors
por: Sykes, David A., et al.
Publicado: (2017)